Stock 9267 GENKY DRUGSTORES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Genky DrugStores Co., Ltd.

Equities

9267

JP3282750003

Drug Retailers

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-02 am EDT 		5-day change 1st Jan Change
5,630 JPY 0.00% Intraday chart for Genky DrugStores Co., Ltd. -2.76% +3.11%
Apr. 30 Genky Drugstores Co., Ltd. Reports Sales Results for the Month and Third Quarter Ended April 2024 CI
Mar. 29 Genky Drugstores Co., Ltd. Reports Sales Results for the Month and Third Quarter Ended March 2024 CI

Valuation

Fiscal Period: Juni 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 39,038 50,996 56,687 47,977 64,380 85,529 - -
Enterprise Value (EV) 1 58,604 74,767 77,330 73,498 91,405 113,529 115,829 117,229
P/E ratio 14.6 x 18.5 x 11.7 x 10.9 x 13.5 x 14 x 13 x 12 x
Yield 0.98% 0.74% 0.67% 0.79% 0.59% 0.44% 0.46% 0.47%
Capitalization / Revenue 0.38 x 0.41 x 0.4 x 0.31 x 0.38 x 0.46 x 0.43 x 0.4 x
EV / Revenue 0.56 x 0.6 x 0.54 x 0.48 x 0.54 x 0.61 x 0.58 x 0.55 x
EV / EBITDA - - 7.47 x 7.16 x - 8.17 x 7.77 x 7.24 x
EV / FCF -9.59 x -19 x 23.8 x -16.3 x -98.8 x 233 x -127 x 176 x
FCF Yield -10.4% -5.26% 4.2% -6.14% -1.01% 0.43% -0.79% 0.57%
Price to Book 1.53 x 1.84 x 1.76 x 1.33 x 1.59 x 1.86 x 1.63 x 1.45 x
Nbr of stocks (in thousands) 15,297 15,177 15,177 15,183 15,184 15,192 - -
Reference price 2 2,552 3,360 3,735 3,160 4,240 5,630 5,630 5,630
Announcement Date 7/19/19 7/27/20 7/27/21 7/26/22 7/24/23 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 103,897 123,603 142,376 154,639 169,059 184,900 199,433 214,000
EBITDA 1 - - 10,354 10,267 - 13,900 14,900 16,200
EBIT 1 4,046 4,341 6,294 5,675 6,709 8,583 9,233 9,900
Operating Margin 3.89% 3.51% 4.42% 3.67% 3.97% 4.64% 4.63% 4.63%
Earnings before Tax (EBT) 1 3,886 4,032 6,662 6,083 6,704 8,680 9,305 10,105
Net income 1 2,697 2,755 4,831 4,420 4,764 6,136 6,618 7,149
Net margin 2.6% 2.23% 3.39% 2.86% 2.82% 3.32% 3.32% 3.34%
EPS 2 174.7 181.5 318.4 291.2 313.8 401.4 433.0 470.8
Free Cash Flow 1 -6,110 -3,935 3,246 -4,513 -925 488 -911 666.5
FCF margin -5.88% -3.18% 2.28% -2.92% -0.55% 0.26% -0.46% 0.31%
FCF Conversion (EBITDA) - - 31.35% - - 3.51% - 4.11%
FCF Conversion (Net income) - - 67.19% - - 7.95% - 9.32%
Dividend per Share 2 25.00 25.00 25.00 25.00 25.00 25.00 26.00 26.50
Announcement Date 7/19/19 7/27/20 7/27/21 7/26/22 7/24/23 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2020 S1 2021 S1 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4
Net sales 1 - 69,117 39,118 37,123 76,241 37,525 40,873 42,613 41,261 83,874 40,331 44,854 46,871 45,096 91,967 44,620 48,572
EBITDA - - - - - - - - - - - - - - - - -
EBIT 1 - 3,230 1,738 1,183 2,921 1,272 1,482 1,584 1,780 3,364 1,394 1,951 2,015 2,372 4,387 2,107 2,109
Operating Margin - 4.67% 4.44% 3.19% 3.83% 3.39% 3.63% 3.72% 4.31% 4.01% 3.46% 4.35% 4.3% 5.26% 4.77% 4.72% 4.34%
Earnings before Tax (EBT) - 3,478 1,847 - 3,123 1,354 - 1,602 - 3,357 1,488 - 2,088 - 4,441 2,019 -
Net income - 2,436 1,232 - 2,132 933 - 1,102 - 2,271 1,042 1,451 1,444 - 3,087 1,369 -
Net margin - 3.52% 3.15% - 2.8% 2.49% - 2.59% - 2.71% 2.58% 3.23% 3.08% - 3.36% 3.07% -
EPS - 160.5 81.19 - 140.5 61.47 - 72.59 - 149.6 68.64 - 95.14 - 203.3 90.09 -
Dividend per Share 12.50 12.50 - - 12.50 - - - - 12.50 - - - - 12.50 - -
Announcement Date - 1/20/21 10/27/21 1/25/22 1/25/22 4/28/22 7/26/22 10/24/22 1/31/23 1/31/23 4/24/23 7/24/23 10/30/23 1/29/24 1/29/24 4/25/24 -
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 19,566 23,771 20,644 25,521 27,025 28,000 30,300 31,700
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) - - 1.994 x 2.486 x - 2.014 x 2.034 x 1.957 x
Free Cash Flow 1 -6,110 -3,935 3,246 -4,513 -925 488 -911 667
ROE (net income / shareholders' equity) 11% 10.4% 16.2% 12.9% 12.4% 14.1% 13.4% 12.8%
ROA (Net income/ Total Assets) 6.73% 6.05% 7.59% 3.78% 6.97% 5.5% 5.3% 5.3%
Assets 1 40,063 45,555 63,650 116,931 68,317 111,558 124,868 134,887
Book Value Per Share 2 1,668 1,824 2,118 2,383 2,674 3,025 3,451 3,895
Cash Flow per Share 2 390.0 429.0 586.0 594.0 640.0 896.0 948.0 1,027
Capex 1 10,410 11,346 9,220 11,333 9,698 11,350 13,050 12,550
Capex / Sales 10.02% 9.18% 6.48% 7.33% 5.74% 6.14% 6.54% 5.86%
Announcement Date 7/19/19 7/27/20 7/27/21 7/26/22 7/24/23 - - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Genky DrugStores Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5,630 JPY
Average target price
7,600 JPY
Spread / Average Target
+34.99%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.
GENKY DRUGSTORES CO., LTD. Stock Genky DrugStores Co., Ltd.
+3.11% 559M
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-31.79% 15.36B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-21.99% 12.45B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-22.64% 6.75B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+9.74% 6.14B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-10.91% 6.07B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
+0.58% 4.78B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+59.24% 4.53B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-9.00% 3.81B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-12.53% 3.43B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. 9267 Stock
  4. Financials Genky DrugStores Co., Ltd.